Malta vs Marshall Islands: The number of people with susceptibility test result for rifampicin
Malta
27
in 2021
Marshall Islands
31
in 2021
Malta rank
129th
Marshall Islands rank
127th
The number of people with susceptibility test result for rifampicin over time
- Malta
- Marshall Islands
How they compare
Marshall Islands currently reports 31 against 27 in Malta, a difference of 4.
That makes Marshall Islands's figure about 1.1 times Malta's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Marshall Islands ahead.
Malta ranks 129th and Marshall Islands ranks 127th of 155 countries.
Across the 2 decades both report, Malta averaged higher in 1 and Marshall Islands in 1.
Head to head by decade
| Decade | Malta | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 29 | 54 | 25 | Marshall Islands |
| 2020s | 30.5 | 25.5 | 5 | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Malta or Marshall Islands?
- Marshall Islands, at 31 against 27 in Malta as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Malta and Marshall Islands?
- 4, with Marshall Islands ahead.
- How many years of comparable data are there for Malta and Marshall Islands?
- 5 years are reported by both, from 2017 to 2021.
- How do Malta and Marshall Islands rank globally for the number of people with susceptibility test result for rifampicin?
- Malta ranks 129th and Marshall Islands ranks 127th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.